Cost-effectiveness and budget impact analysis of lisdexamfetamine versus methylphenidate for patients under 18 with attention-deficit/hyperactivity disorder in Iran

• Главные авторы: Amirmohammad Tajik (Автор), Shekoufeh Nikfar (Автор), Sepideh Elyasi (Автор), Omid Rajabi (Автор), Mehdi Varmaghani (Автор)
• Формат: ‌
• Опубликовано: BMC, 2023-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract Background Lisdexamfetamine (LDX) and Methylphenidate (MPH) are stimulant agents that have been shown to provide significant benefits in the management of attention-deficit/hyperactivity disorder (ADHD) in patients. Aim This study aimed to assess the cost-effectiveness and the budget impact...